Clinical experience to date suggests stem cell therapy for inflammatory bowel disorders can promote longer periods of remission and reduce the frequency and duration of relapses.

• 临床实验显示通过对炎性肠病的干细胞治疗能延长缓解期及缩短复发期的频率和持续时间。